Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2020.386 | Evaluation of Small Vessel Disease by 3D-rotational Angiography |
Dr. IP Bonaventure Yiu Ming 葉耀明 |
| 2018.645 | Evolution of ischaemic stroke subtype in Hong Kong | Dr. IP Bonaventure Yiu Ming |
| 2020.376 | Monitoring of NOAC therapy: standardizing reference intervals |
Dr. IP Bonaventure Yiu Ming 葉耀明 |
| 2020.427 | Ischemic Strokes while on NOAC – how compliance matters |
Dr. IP Bonaventure Yiu Ming 葉耀明 |
| 2024.514 | Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies – A phase 3, multicenter, prospective, randomized, open-label, blinded end-point trial (GALLOP-2 study) | Dr. IP Bonaventure Yiu Ming |
| 2025.039 | Regional Brain Eloquence in Prediction of Thrombectomy Outcomes (REROUTE) – A Territory-Wide Study | Dr. IP Bonaventure Yiu Ming |
| 2023.524 | Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on Direct Oral Anticoagulants – A Prospective Multicenter Study | Dr. IP Bonaventure Yiu Ming |
| 2024.388 | Prevalence of Small Vessel Disease in Patients with Cardiovascular Risk Factors - A hospital-based study | Dr. IP Bonaventure Yiu Ming |
| 2025.410 | Analysis of tracking patients in secondary transportation in acute stroke patients: a survey and systematic review | Dr. IP Bonaventure Yiu Ming |
| 2024.304 | Evaluation of serum glial fibrillatory acidic protein and serum neurofilament light chain as biomarkers for patients with multiple sclerosis in Hong Kong | Dr. IP Bonaventure Yiu Ming |
| 2025.319 | App-assisted implementation of evidence-based management of acute intracerebral haemorrhage |
Dr. IP Bonaventure Yiu Ming 葉耀明 |
| 2024.373 | Risk of non-arteritic anterior ischemic optic neuropathy with glucagon-like peptide-1 receptor agonist – a territory-wide study | Dr. IP Bonaventure Yiu Ming |
| 2025.867 | Brain Health Outcomes Of Direct Oral Anticoagulant Therapy With Versus Without Catheter Ablation in Patients With Atrial Fibrillation: A Randomized Trial | Prof. Ip Bonaventure Yiu Ming |
| 2024.691 | International Care Bundle Evaluation in Cerebral Hemorrhage Research – a batched parallel cluster-randomized trial with a baseline period | Dr. IP Bonaventure Yiu Ming |
| 2024.136 | Brain Health in Atrial Fibrillation – a prospective study | Dr. IP Bonaventure Yiu Ming |
| 2023.602 | Precision Research Integrating Multiomics, Gut Microbiome and Advanced Imaging Assessment for Stroke, Neuroinflammatory and Neurodegenerative Diseases – PRIMMA Consortium | Dr. IP Bonaventure Yiu Ming |
| 2024.430 | Cardio- and Cerebrovascular Disease Biobank for Research | Dr. IP Bonaventure Yiu Ming |
| 2016.545 | Gut microbiota in acute stroke patients |
Dr. IP Bonaventure Yiu Ming 葉耀明 |
| 2014.359 | Risk of Intracerebral Haemorrhage in Patients Taking Oral Anticoagulants for Atrial Fibrillation with Cerebral Microbleeds. A Prospective Study in Novel Oral Anticoagulants. (IPAAC-NOAC Study) | Dr. Ip Bonaventure Yiu Ming |
| 2026.169 | GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial | Prof. IP Bonaventure Yiu Ming |
| 2021.627 | Comparative efficacy and safety of treatments in Intracerebral Bleeding during Direct Oral Anticoagulant Usage – a population-based study |
Dr. IP Bonaventure Yiu Ming 葉耀明 |
| 2021.028 | A pilot randomized controlled trial of integrative Motivational Interviewing and Contingency Management program (MICM) for dual-diagnosed patients to enhance psychiatric medication adherence |
Mr. IP Chi Kin 葉志堅 |
| 2026.263 | VR-AI Enhanced Anger Management For Patients with Severe Mental Illness: A Pilot Randomized Controlled Trial |
Dr. Ip Chi Kin 葉志堅 |
| 2026.244 | The use of accelerated protocol of intermittent Theta Burst Stimulation on the Craving for Stimulant abusers (TBC-S): A pilot double-blinded randomised controlled trial |
Dr. Ip Chi Kin 葉志堅 |
| 2026.468 | Understanding the reasons and perspectives regarding hidden substance use: a focus group approach |
Dr. Ip Chi Kin 葉志堅 |
| 2026.470 | Identification of hidden substance users: a data-driven approach |
Dr. Ip Chi Kin 葉志堅 |
| 2020.383 | Effect of Acceptance and Commitment Therapy-based lifestyle counselling programme for people with early psychosis on physical activity: a pilot randomized controlled trial |
Mr. IP Chi Kin 葉志堅 |
| 2017.381 | The feasibility study over the outcomes of substance abusers in residential detox centers when compared with video medical consultation verus face-to-face consultation |
Mr. IP Chi Kin 葉志堅 |
| 2025.709 | Acceptance and Commitment Therapy-based lifestyle counselling programme on physical activity in people with recent-onset psychosis: A randomised controlled trial | Dr. IP CHI KIN |
| 2025.881 | The use of accelerated protocol of intermittent Theta Burst Stimulation on the Craving for Hypnotic abusers (TBC-H): A double-blinded randomized controlled trial |
Dr. Ip Chi Kin 葉志堅 |
| 2025.718 | The use of accelerated protocol of intermittent Theta Burst Stimulation on the Craving and sleep for Hypnotic abusers (TBC-H): A pilot randomized controlled trial |
Dr. IP Chi Kin 葉志堅 |
| 2025.470 | Developing and Evaluating the Effects of a Virtual AI-De-escalation Education Programme on Confidence and Knowledge on Managing Aggressive Behaviour, patients' restraint rate and staff wellbeing: A Pilot Cluster Randomised Controlled Trial in Psychiatric Nursing Care |
Dr Ip Chi Kin 葉志堅 |
| 2022.290 | A Fifteen-year Retrospective Review on Livedoid Vasculopathy in a Tertiary Centre | Dr. IP Edric Chi Ching |
| 2024.209 | Molecular Characterization of CDKL5 Deficiency Disorders (CDD) with Human Brain Samples | Prof. IP Jacque Pak Kan |
| 2024.329 | Mindfulness Intervention for Reducing Stress and Anxiety in Postnatal Women: A Six-Week Program | Dr. IP KA HIM |
| 2014.625 | The prevalence and risk factors associated with the use of Potentially Inappropriate Medication in Old Age Homes and Prince of Wales Hospital - a retrospective cohort study | Student Ip Kai Cheung |
| 2008.494 | Compare the Clinical Outcomes of Non-operative Versus Operative Treatment in Mason Type II Radial Head Fracture, Restrospective Study | DR IP Kai Yuen |
| 2010.305 | Evaluation of a nurse-led Comprehensive Child Development Service Program for high risk pregnant women in Hong Kong | Ms Ip Lai Sheung |
| 2012.054 | Clinical Outcome of Streptococcus agalactiae or group B streptococcus (GBS) Basteremia and Invasive Diseases among Adults in Hong Kong | Prof Ip Margaret |
| 2009.068 | Clinical and Economic Impact of Nosocomial Acinetobacter Baumannii Bacteremia | Prof. Ip Margaret |
| 2010.389 | Multi-center evaluation of the burden of invasive neonatal group B streptococcal disease: Incidence and Serotype Distribution | Prof Ip Margaret |
| 2012.049 | A three year review on Serotypes and In-vitro Antibiotic Susceptibilitics of Streptococcus pneumoniae from Hospitalized Adult Pateitns in a Hong Kong Hospital, 2009-2011 | Prof Ip Margaret |
| 2008.297 | Comparative Activity of Carbapenem Testing Etest Study (COMPACT) | Dr. Ip Margaret |
| 2015.519 | A review on Serotypes and In-vitro Antibiotic Susceptibilities of Streptococcus pneumoniae from Hospitalized Adult Patients in a Hong Kong Hospital, 2012 - 2014. |
Prof. IP Margaret 葉碧瑤 |
| 2017.152 | Whole Genome Sequencing-based characterization of Carbapenem-resistant Enterobacteriaceae in Hong Kong | Prof. IP Margaret |
| 2016.043 | Epidemiology and Detection of Carbapenemase-Producing Enterobacteriaceae (CPE) in Hong Kong hospitals |
Prof. IP Margaret 葉碧瑤 |
| 2017.448 | A review on Serotypes and In-vitro Antibiotic Susceptibilities of Streptococcus pneumoniae from Hospitalized Adult Patients in a Hong Kong Hospital, 2015 - 2016. | Prof. IP Margaret |
| 2017.230 | Dissecting human and animal Streptococcus agalactiae (Group B streptococcus) and its resistance determinants through territory-wide sampling | Prof. IP Margaret |
| 2014.403 | Impact of macrolide non susceptibility in Mycoplasma pneumoniae on childhood respiratory diseases | Prof Ip Margaret |
| 2013.452 | The Evaluation of Computer Aided Pathology Diagnosis system for Tuberculosis Sputum Smear. | Prof. Ip Margaret |
Page 111 of 288.